06-Nov-2026 15:07:49
CAMLINFINE : BOARD APPROVES RIGHTS ISSUE WORTH RS 250 CR
• Board approved rights issue of around ₹250 Cr; draft letter of offer to be filed with exchanges by November 7, 2026 • Promoters to subscribe to their entitlement of about 48%; final equity dilution depends on pricing decision in coming weeks • Proceeds to be used for augmenting working capital and unwinding channel financing; no project finance planned • Company expects to be in funds by end of this calendar year or early next year; Q3 to be similar to Q2 • Management guides Q4 FY27 top line of ₹600 Cr and EBITDA of ₹60 Cr plus, with turnaround expected in Q4 Q2 FY27 EBITDA margin fell to 2.5% from 3.4% on channel-financing costs, and the earlier ₹200 Cr FY27 EBITDA target is no longer achievable
Camlin Fine Sciences Ltd
Open attachment